Trials / Completed
CompletedNCT06089044
Evaluation of the Efficacy and Safety of Suppressive Therapy With DALBAVANCINE in Device Infections
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 15 (actual)
- Sponsor
- Tourcoing Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this retrospective observational study is to evaluate the efficacy of antibiotic therapy with dalbavancin in patients presenting with infection on prosthetic devices. The main questions the study aims to answer are: What is the proportion of patients with early discontinuation of dalbavancin therapy? What are the reasons for early discontinuation of antibiotic treatment? What adverse events do patients report? The study is based on data collected as part of routine care practices. Translated with www.DeepL.com/Translator (free version)
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Dalbavancin Injection | Dalbavancin as long-term suppressive therapy. |
Timeline
- Start date
- 2020-01-01
- Primary completion
- 2022-12-31
- Completion
- 2022-12-31
- First posted
- 2023-10-18
- Last updated
- 2023-10-18
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT06089044. Inclusion in this directory is not an endorsement.